Blueprint
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
 
 
Date of Report (Date of earliest event reported)
May 16, 2018
 
SANUWAVE HEALTH, INC.
(Exact name of registrant as specified in its charter)
 
Nevada
000-52985
20-1176000
(State or other jurisdiction
of incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
 
3360 Martin Farm Road, Suite 100, Suwanee, Georgia
30024
(Address of principal executive offices)
(Zip Code)
 
Registrant’s telephone number, including area code
(770) 419-7525
 
N/A
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Indicate by check mark whether the registration is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.
 
Emerging growth company.
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 
 
 
Item 2.02        
Results of Operations and Financial Condition.
 
On May 16, 2018, SANUWAVE Health, Inc., a Nevada Corporation (the "Company"), announced its financial results for the three months ended March 31, 2018 and provided a business update via conference call. A copy of the related press release is furnished as Exhibit 99.1 to this Form 8-K. A copy of the transcript of such call is furnished as Exhibit 99.2 to this Form 8-K.
 
The information in this Item 2.02 of this Current Report on Form 8-K and the exhibits attached hereto shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.
 
 
Item 9.01            
Financial Statements and Exhibits.
 
(d)           
Exhibits.
 
Exhibit No.
Description
 
99.1
Press release, dated May 16, 2018, issued by SANUWAVE Health, Inc., titled “SANUWAVE Health reports first quarter financial results and provides a business update.”
 
99.2
Transcript of the May 16, 2018, SANUWAVE Health, Inc. conference call to discuss the three months ended March 31, 2018 financial results and provide a business update.
 
 
 
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
SANUWAVE HEALTH, INC.
 
 
 
 
 
Dated: May 18, 2018
By:  
/s/ Lisa E. Sundstrom
 
 
Name:  
Lisa E. Sundstrom 
 
 
Title:  
Controller and Chief Financial Officer